Vest Financial LLC Has $52.29 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Vest Financial LLC raised its position in Colgate-Palmolive (NYSE:CL) by 13.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 575,181 shares of the company’s stock after buying an additional 69,982 shares during the period. Vest Financial LLC’s holdings in Colgate-Palmolive were worth $52,290,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Atomi Financial Group Inc. grew its position in Colgate-Palmolive by 12.8% during the 3rd quarter. Atomi Financial Group Inc. now owns 6,095 shares of the company’s stock worth $633,000 after acquiring an additional 692 shares during the last quarter. Brookstone Capital Management boosted its stake in Colgate-Palmolive by 11.7% in the third quarter. Brookstone Capital Management now owns 17,366 shares of the company’s stock worth $1,803,000 after purchasing an additional 1,814 shares in the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of Colgate-Palmolive during the third quarter worth $339,000. CWM LLC increased its stake in shares of Colgate-Palmolive by 28.7% in the third quarter. CWM LLC now owns 35,216 shares of the company’s stock valued at $3,656,000 after buying an additional 7,861 shares in the last quarter. Finally, Hexagon Capital Partners LLC raised its holdings in shares of Colgate-Palmolive by 9.8% in the third quarter. Hexagon Capital Partners LLC now owns 1,399 shares of the company’s stock valued at $145,000 after buying an additional 125 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Price Performance

CL opened at $86.81 on Friday. The stock has a market cap of $70.93 billion, a P/E ratio of 24.66, a P/E/G ratio of 3.61 and a beta of 0.44. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The company has a fifty day simple moving average of $90.56 and a 200 day simple moving average of $96.84.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company earned $0.87 earnings per share. On average, research analysts expect that Colgate-Palmolive will post 3.74 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Wall Street Analyst Weigh In

CL has been the topic of a number of research analyst reports. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Barclays lowered their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Finally, Morgan Stanley cut their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.